Final answer:
The rapid hydrolysis of activated C3b in solution prevents it from binding to and damaging host cells, thus ensuring that the complement system targets only pathogens and not the body's own tissues.
Step-by-step explanation:
The question pertains to the mechanism by which host cells are protected from the potentially harmful effects of activated C3b during the complement activation process. In all three pathways of complement activation—the classical pathway, the alternative pathway, and the lectin pathway—the formation of C3 convertase is crucial as it cleaves the C3 molecule into C3a and C3b. The C3b fragment, which is then able to bind covalently to pathogen surfaces, has a reactive thioester group that must be controlled to avoid damage to host cells.
In this context, the correct answer is C: The rapid hydrolysis of active C3b in solution, renders it inactive. This mechanism ensures that the activated C3b that does not immediately find a pathogenic target becomes hydrolyzed and thereby inactivated before it can bind to and potentially damage host cells. Moreover, endogenous regulatory proteins present in the host's body help to prevent the binding of complement components like C3b to host cells, allowing for a distinction between self and non-self cells.
I choose only one option: the rapid hydrolysis of active C3b in solution, rendering it inactive, which is essential for preventing the attachment of C3b to host cells, thus avoiding host tissue damage during the immune response.